| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | interleukin 3 receptor subunit alpha | ||||
| GTO ID | GTC3268 |
| Trial ID | NCT05645744 |
| Disease | Hairy Cell Leukemia | Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma | Small Lymphocytic Lymphoma | Blastic Plasmacytoid Dendritic Cell Neoplasm | B-Cell Lymphoma | B-Cell Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia |
| Altered gene | CD123 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MB-102 CAR-T cells |
| Recruitment status | Recruiting |
| Title | Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product. |
| Year | 2022 |
| Country | United States |
| Company sponsor | Mustang Bio |
| Other ID(s) | MB100-OBS-001 |
| Cohort 1 | |||||||
|
|||||||